Direkt zum Inhalt
Merck
  • Temporal Dissection of Rate Limiting Transcriptional Events Using Pol II ChIP and RNA Analysis of Adrenergic Stress Gene Activation.

Temporal Dissection of Rate Limiting Transcriptional Events Using Pol II ChIP and RNA Analysis of Adrenergic Stress Gene Activation.

PloS one (2015-08-06)
Daniel P Morris, Beilei Lei, Lawrence D Longo, Karol Bomsztyk, Debra A Schwinn, Gregory A Michelotti
ZUSAMMENFASSUNG

In mammals, increasing evidence supports mechanisms of co-transcriptional gene regulation and the generality of genetic control subsequent to RNA polymerase II (Pol II) recruitment. In this report, we use Pol II Chromatin Immunoprecipitation to investigate relationships between the mechanistic events controlling immediate early gene (IEG) activation following stimulation of the α1a-Adrenergic Receptor expressed in rat-1 fibroblasts. We validate our Pol II ChIP assay by comparison to major transcriptional events assessable by microarray and PCR analysis of precursor and mature mRNA. Temporal analysis of Pol II density suggests that reduced proximal pausing often enhances gene expression and was essential for Nr4a3 expression. Nevertheless, for Nr4a3 and several other genes, proximal pausing delayed the time required for initiation of productive elongation, consistent with a role in ensuring transcriptional fidelity. Arrival of Pol II at the 3' cleavage site usually correlated with increased polyadenylated mRNA; however, for Nfil3 and probably Gprc5a expression was delayed and accompanied by apparent pre-mRNA degradation. Intragenic pausing not associated with polyadenylation was also found to regulate and delay Gprc5a expression. Temporal analysis of Nr4a3, Dusp5 and Nfil3 shows that transcription of native IEG genes can proceed at velocities of 3.5 to 4 kilobases/min immediately after activation. Of note, all of the genes studied here also used increased Pol II recruitment as an important regulator of expression. Nevertheless, the generality of co-transcriptional regulation during IEG activation suggests temporal and integrated analysis will often be necessary to distinguish causative from potential rate limiting mechanisms.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Albumin aus Rinderserum, lyophilized powder, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Formaldehyd -Lösung, Molecular Biology, 36.5-38% in H2O
Sigma-Aldrich
Formaldehyd -Lösung, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥98.5% (GC)
Sigma-Aldrich
Deoxycholsäure Natriumsalz, BioXtra, ≥98.0% (dry matter, NT)
Sigma-Aldrich
Deoxycholsäure Natriumsalz, ≥97% (titration)
Sigma-Aldrich
Formaldehyd -Lösung, Molecular Biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥99.0% (T)
Sigma-Aldrich
Natriumorthovanadat, ≥90% (titration)
Sigma-Aldrich
Natriumorthovanadat, 99.98% trace metals basis
SAFC
Deoxycholsäure Natriumsalz
Sigma-Aldrich
Formaldehyd -Lösung, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Glycogen aus Austern, ≥75% dry basis
Sigma-Aldrich
(R)-(−)-Phenylephrin -hydrochlorid, powder
Sigma-Aldrich
Natriumfluorid, 99.99% trace metals basis
Sigma-Aldrich
Natriumfluorid, BioXtra, ≥99%
Sigma-Aldrich
Natriumfluoridlösung
Sigma-Aldrich
Natriumfluorid, BioReagent, suitable for insect cell culture, ≥99%
Sigma-Aldrich
Formaldehyd-12C -Lösung, 20% in H2O, 99.9 atom % 12C
Sigma-Aldrich
3-[(1R)-1-Hydroxy-2-(methylamino)ethyl]phenol, AldrichCPR